PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.
HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria
Empowering future leaders with essential skills to combat climate change
HONG KONG,March 3,2025-- AXA Hong Kong and Macau("AXA") launched the AXA Climate School in 2022,aimingto empower youn
SHENZHEN,China,March 3,2025-- UBTECH has successfully conducted the world\'s first collaborative practical training program for humanoid robots at ZEEKR\'s 5G Intelligent Factory,where multiple humano
First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model
NEW YORK,March 3,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,t
LISHUI,China,March 3,2025-- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") announced today that on February 28,2025,it received notification from The Nasdaq Stock
HONG KONG,March 4,2025-- Hong Kong Baptist University (HKBU) won four gold medals atthe 15th International Invention Fair in the Middle East (IIFME) held in Kuwait from 16 to 19 February.It was the fi
